1. 2-(3,4-dihydroxyphenyl)ethanol
2. 3,4-dihydroxyphenylethanol
3. Beta-3,4-dihydroxyphenylethyl Alcohol
4. Dopet
1. 10597-60-1
2. 3,4-dihydroxyphenylethanol
3. 2-(3,4-dihydroxyphenyl)ethanol
4. 4-(2-hydroxyethyl)benzene-1,2-diol
5. Dopet
6. 3,4-dihydroxyphenethyl Alcohol
7. 3-hydroxytyrosol
8. 1,2-benzenediol, 4-(2-hydroxyethyl)-
9. 2-(3,4-dihydroxyphenyl)ethyl Alcohol
10. 3,4-dihydroxyphenethylalcohol
11. 4-(2-hydroxyethyl)-1,2-benzenediol
12. Beta-3,4-dihydroxyphenylethyl Alcohol
13. Dihydroxyphenylethanol
14. Mfcd01320529
15. Qeu0ne4o90
16. Chebi:68889
17. Unii-qeu0ne4o90
18. Dopaol
19. 3,4-dihydroxy-1-benzeneethanol
20. 4-(2-hydroxy-ethyl)-benzene-1,2-diol
21. Hydroxytyrosol [mi]
22. Schembl44363
23. Hydroxytyrosol [inci]
24. 3,4-dhpea
25. Hydroxytyrosol [who-dd]
26. Chembl1950045
27. Ba2774
28. Juubchwrxwpffh-uhfffaoysa-
29. Dtxsid70147451
30. Ba 2774
31. Bcp31094
32. Hy-n0570
33. Zinc2379217
34. 2-(3,4-di-hydroxyphenyl)-ethanol
35. S3826
36. 3-hydroxytyrosol, >=98% (hplc)
37. 3-hydroxytyrosol, Analytical Standard
38. Akos003368868
39. Ac-5308
40. Ccg-266246
41. Db12771
42. As-10017
43. Sy017402
44. Db-008830
45. Am20020163
46. Cs-0009107
47. D2756
48. Ft-0600597
49. Ft-0670206
50. N2302
51. 597d601
52. A801346
53. Q744577
54. Q-100040
55. Brd-k04809113-001-01-7
56. 3,4-dihydroxyphenethyl Alcohol;3,4-dihydroxyphenyl Ethanol
Molecular Weight | 154.16 g/mol |
---|---|
Molecular Formula | C8H10O3 |
XLogP3 | -0.7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 154.062994177 g/mol |
Monoisotopic Mass | 154.062994177 g/mol |
Topological Polar Surface Area | 60.7 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 116 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
LOOKING FOR A SUPPLIER?